Mumbai: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.
The inspection was conducted from 17th March, 2025 to 21st March, 2025.
Leave a Reply